Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bioprocessing - Upstream & Downstream


Intensify, Connect, and Continue

Thanks to the emergence of intensified and connected processes, the path to continuous biopharma manufacturing is open.

Discovery & Development

Boosting mAb Manufacture

| David Westman

mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.

Discovery & Development

ADCs Assemble

| Charlie Johnson

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.


Trials of a Medicine Maker

The challenge of convincing senior staff to invest in continuous bioprocessing.


Flexibility without compromise


Mastering mAb Manufacture

Experts share their tips and tricks for enhancing the production of monoclonal antiboides


Trials of a Medicine Maker

Gene and Eva discuss the importance of being cautious when choosing a new supplier.


How to Beat the Bottleneck

| Sponsored by GE Healthcare

Now is the time to push bioprocess efficiencies even further...


Preparing for the Paradigm Shift in Bioprocessing

In chromatography, we must continually strive to improve productivity, quality and overall process economy.


The Continuous Way

| Sponsored by Pall Biotech

Are we entering a new era of continuous bioprocessing? Pall’s experts discuss the opportunities and challenges ahead.

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine


December Issue of The Medicine Maker